Prasad Kulkarni on dengue monoclonal antibodies

Update: 2024-02-23

Description

Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development.

Read the full article:
https://www.thelancet.com/journals/laninf/article/ S1473-3099(24)00030-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Comments

In Channel

Anna Odone, Jesus Rodriguez-Manzano, and Alex Howard on artificial intelligence and infectious diseases

2025-09-1629:12

Catherine Liu and Joshua Hill on prevention and management of infections in people who are immunocompromised

2025-08-1118:27

Lilian Tina Minja and Norbert Heinrich on TB drug development

2025-07-0929:53

Leonardo Basso and Juan Pablo Torres on the NIRSE-CL study of nirsevimab in Chile

2025-06-1015:27

Jan Felix Drexler and Fernando Bozza on Oropouche virus

2025-04-1435:17

Prasad Kulkarni on dengue monoclonal antibodies

2024-02-2318:53

Oriol Mitjà on treatment of early syphilis in adults

2024-01-0815:25

Sofia Viegas and Stefan Niemann on emerging bedaquiline resistance in Mozambique

2023-11-1024:35

Luciano Moreira and Henrik Salje on Wolbachia control of mosquito-borne infections

2022-09-2717:01

Richard Maude on malaria chemoprophylaxis in Cambodia

2022-09-2712:44

Ben Cowling on COVID-19 vaccines in Hong Kong

2022-07-1520:58

Hugh Adler on monkeypox in the UK

2022-05-2618:17

Beate Kampmann, Karen Keddy, and Peter Ghazal on applying big data to childhood infectious diseases in LMICs

2021-12-1422:16

Laura Cooper and Sam Okiror on polio eradication in Africa

2021-10-1221:34

Paul Chapman on a hookworm vaccine

2021-08-1920:57

Josep Llibre on preventing SARS-CoV-2 transmission at concerts

2021-05-2708:10

Yap Boum on COVID-19 testing in low resource settings

2021-03-2511:21

Antimalarial resistance in southeast Asia

2019-07-2513:06

Trial in phage therapy for burn infections

2018-10-0429:29

Pandemic influenza: 100 years

2018-06-2118:34

00:00

1.0x

Prasad Kulkarni on dengue monoclonal antibodies

#box-pro-ellipsis-175975718722694{-webkit-line-clamp:2;}Prasad Kulkarni on dengue monoclonal antibodies

Prasad Kulkarni on dengue monoclonal antibodies

The Lancet Group

Prasad Kulkarni on dengue monoclonal antibodies